Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy?

Source:http://linkedlifedata.com/resource/pubmed/id/11421877

Download in:

View as

General Info

PMID
11421877